90 related articles for article (PubMed ID: 22402308)
1. The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.
Han SX; Wang L; Wu DQ
Cancer Epidemiol; 2012 Aug; 36(4):e201-6. PubMed ID: 22402308
[TBL] [Abstract][Full Text] [Related]
2. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of UGT1A7 and cancer risk: evidence from 21 case-control studies.
Lu PH; Chen MB; Wu XY; Gu JH; Liu Y; Gu RM
Cancer Invest; 2011 Dec; 29(10):645-54. PubMed ID: 22085268
[TBL] [Abstract][Full Text] [Related]
4. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer.
Araki J; Kobayashi Y; Iwasa M; Urawa N; Gabazza EC; Taguchi O; Kaito M; Adachi Y
Eur J Cancer; 2005 Oct; 41(15):2360-5. PubMed ID: 16143514
[TBL] [Abstract][Full Text] [Related]
6. Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer.
Butler LM; Duguay Y; Millikan RC; Sinha R; Gagné JF; Sandler RS; Guillemette C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1626-32. PubMed ID: 16030093
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer.
Vogel A; Ockenga J; Ehmer U; Barut A; Kramer FJ; Tukey RH; Manns MP; Strassburg CP
Z Gastroenterol; 2002 Jul; 40(7):497-502. PubMed ID: 12122597
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
11. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
Qiu LX; Yuan H; Yu KD; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Jun; 121(3):703-8. PubMed ID: 19936916
[TBL] [Abstract][Full Text] [Related]
13. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
14. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
15. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis.
Li Y; Gu S; Wu Q; Li Y; Fu X; Mao Y; Huang Y; Xie Y
Eur J Hum Genet; 2007 Sep; 15(9):967-73. PubMed ID: 17522621
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases.
Verlaan M; Drenth JP; Truninger K; Koudova M; Schulz HU; Bargetzi M; Künzli B; Friess H; Cerny M; Kage A; Landt O; te Morsche RH; Rosendahl J; Luck W; Nickel R; Halangk J; Becker M; Macek M; Jansen JB; Witt H
J Med Genet; 2005 Oct; 42(10):e62. PubMed ID: 16199544
[TBL] [Abstract][Full Text] [Related]
17. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
19. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
20. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
